Try proving up your statements. Come on Chubby let's twist it again. $CYDY$ 2024
Leronlimab, in a class of it's own. A monoclonal antibody that works and has almost no side effects except maybe a runny nose. Although the thought of leronlimab getting back into trials has some short traders squirming. Go Dr.Jay.